Back to search

McMaster University

The role of integrin beta 1 activation in the profibrotic cell surface GRP78/alpha 2-macroglobulin pathway and chronic kidney disease

Abstract

dc:description.abstract

Chronic kidney disease is a condition characterized by poor renal capacity driven by inflammation and fibrosis of the nephron. As of current, there is an imperative to develop therapies which target profibrotic pathways, as there are relatively few clinically approved medications that help attenuate diabetic kidney disease progression. Kidney fibrosis is a process of tissue stiffening that is often preceded by cellular stress induced by factors such as hyperglycemia, hypertension, and more. This leads to an excess of extracellular matrix protein deposition within the nephron, creating build-up of scar tissue that disrupts normal kidney function. The disease is progressive, and often incurable at the end stage, becoming life-threatening without renal replacement therapy. The process of fibrosis within the nephron involves a plethora of pathways, which may interact or overlap. However, transforming growth factor-beta (TGFβ-1) remains a central promoter of this process. Unfortunately, directly targeting it as a therapeutic strategy has been unsuccessful due to its role in maintaining homeostasis. Instead, our lab has worked to uncover pathways which indirectly modulate TGF-β1 signaling. This led to the discovery of, csGRP78, a stress-induced ER chaperone protein that can translocate to the cell surface and bind to its ligand, α2M*. The interaction between csGRP78 and α2M* leads to downstream fibrotic pathways activation, including those typically associated with integrin β1 signaling. Despite the implication of the integrin β1 receptor’s involvement in the pathway, its role within its axis remains unknown. This study focuses on further elucidating the role of integrin β1 activation within the context of the profibrotic α2M*/csGRP78 pathway and DKD progression. Overall, we aim to identify the importance of integrin β1 to regulation of csGRP78 signaling, with the eventual goal of establishing a potential therapeutic strategy aimed at targeting integrin β1/csGRP78 interaction as a potential therapeutic for kidney fibrosis.

Degree

thesis:*
Department dc:contributor.department
Medical Sciences
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Mamai, Mariam
Advisor dc:contributor.advisor
  • Krepinsky, Joan

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivs 2.5 Canada
Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
McMaster University
Base URL
macsphere.mcmaster.ca/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mamai, Mariam. The role of integrin beta 1 activation in the profibrotic cell surface GRP78/alpha 2-macroglobulin pathway and chronic kidney disease. 2026. https://hdl.handle.net/11375/33802